#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Behcet's syndrome Uveitis Synovitis Infantile apnoea X-linked lymphoproliferative syndrome Pancreatic carcinoma metastatic Liposarcoma Interstitial lung disease Hodgkin's disease refractory Mycobacterium abscessus infection Haematological malignancy Osteosarcoma metastatic Soft tissue sarcoma Sarcoma Diffuse large B-cell lymphoma recurrent More trials…

    Learn about Rare Diseases

    Urea cycle disorder – Life with Disease Primary mediastinal large B-cell lymphoma – Treatment Proteus syndrome – Life with Disease KBG syndrome – Treatment Indolent systemic mastocytosis – Basic Information Activated PI3 kinase delta syndrome – Life with Disease Prolymphocytic leukaemia – Trials in Disease Familial amyotrophic lateral sclerosis – Diagnostics Nodal marginal zone B-cell lymphoma – Trials in Disease Sjogren’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Meldonium DROSPIRENONE Nido-361 AMODIAQUINE Reboxetine Immunglobulin Hydrochlorothiazide Obinutuzumab Triptorelin Pamoate Calcipotriol Serpina1(Human)-Aav8-1 Chlorphenamine Iopromide Cd19-Car_Lenti_Allo Int-787 Tremelimumab Amantadine Hemisulfate Ammonium Chloride Acetazolamide Sodium Bendamustine More therapies…

    Learn about Your Condition

    Atrophic vulvovaginitis Urticaria Rectal adenocarcinoma Basal cell carcinoma Chronic hepatitis C Retroperitoneal fibrosis Herpes simplex reactivation Head injury Colorectal cancer stage II Metastases to peritoneum Limb reduction defect Measles Malabsorption Procedural hypotension Tubulointerstitial nephritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Non-small cell lung cancer

  • Study on Afatinib and Osimertinib for Patients with EGFR-Mutated, T790M Negative Non-Squamous Non-Small Cell Lung Cancer in First-Line Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Afatinib
    • Osimertinib
    Germany

  • Study on the Effects of Pembrolizumab, Atezolizumab, and Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Atezolizumab
    • Carboplatin
    • Cisplatin
    France

  • Study of MK-2870 and Chemotherapy for Patients with Advanced EGFR-Mutated Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • H2-Receptor Antagonist
    • Sacituzumab Tirumotecan
    • Pemetrexed Disodium
    France Italy Poland Spain Sweden

  • Study of datopotamab deruxtecan combined with immunotherapy and carboplatin in patients with advanced or metastatic non-small cell lung cancer

    Not recruiting

    1 1 1 1
    Investigated Drugs:
    • Sabestomig
    • Volrustomig
    • Rilvegostomig
    Belgium Italy Poland Spain

  • Study on Livmoniplimab and Budigalimab with Chemotherapy for Adults with Untreated Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Budigalimab
    • Livmoniplimab
    • Carboplatin
    Belgium France The Netherlands Spain

  • Study Comparing Sacituzumab Govitecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Treatments

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Sacituzumab Govitecan
    • Docetaxel
    Austria Belgium France Germany Greece Italy +4
Previous Page
1 … 41 42 43 44 45 … 54
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!